Understanding lower urinary tract symptoms in Chinese men
Official title: Status of Disease Burden of Lower Urinary Tract Symptoms in Chinese Male Community
Run by Chinese PLA General Hospital · NCT06352736 · Data updated 2026-11-12
This study looks at how common lower urinary tract symptoms are in Chinese men and what factors might be linked to these symptoms, while also checking how many men are getting treated for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | Men only |
| Enrollment | 12567 (estimated) |
| Sponsor | Chinese PLA General Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | August 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 25, 2025 |
| Trial ID | NCT06352736 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Chinese males aged 40 or older who have lived in the survey area for at least six months.
✕Probably not a fit
Patients living in closed communities, such as armed forces or nursing homes, or those with mental illnesses that hinder cooperation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study conducts a cross-sectional survey to assess the disease burden of lower urinary tract symptoms (LUTS) among the male population in China. It aims to determine the overall and age-specific prevalence rates of LUTS, while also exploring correlations with urbanization, geographical distribution, and lifestyle factors. The study employs a multi-stage sampling method across various regions and urban-rural settings to gather comprehensive data. Additionally, it examines treatment patterns for LUTS, including the proportion of patients receiving treatment and the types of interventions used.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the prevalence and management of LUTS, potentially leading to improved public health strategies and treatment options for affected patients.
How similar studies have gone: While this study focuses on a specific demographic in China, similar studies in other regions have successfully highlighted the prevalence and impact of LUTS, suggesting that this approach may yield valuable findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Mainland China, aged 40 or older, male, in 31 provincial-level administrative regions. 2. Have resided for a total of 6 months or more in the survey county (district) in the past 12 months. 3. Normal communication, cooperation during physical examination, and good cognitive ability. 4. Willing to participate in and cooperate with this study, and sign the informed consent form. Exclusion Criteria: 1. Closed communities, such as armed forces and nursing homes. 2. Individuals with mental illnesses or other conditions that prevent cooperation.
Where it's running
-
Chinese PLA General Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Qing Yuan, Doctor's degree
- Email: qyuanmd@outlook.com
- Phone: 18910980422
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate
This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.
-
Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia
This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.
-
Water Vapor Therapy versus Ejaculation-Preserving HoLEP for Benign Prostatic Hyperplasia
This study compares Rezum water vapor therapy to ejaculation-preserving HoLEP in sexually active men with moderate-to-severe symptoms from BPH to see which preserves ejaculation better while easing urinary symptoms.
-
Ejaculation-Preserving Bipolar Prostate Enucleation for BPH
This randomized trial tests whether a modified ejaculation-preserving bipolar TUEP can maintain ejaculation while still relieving urinary symptoms in sexually active men with BPH who didn’t improve with meds.
-
Melatonin and Solifenacin for stent-related symptoms after ureteroscopy
This study tests whether solifenacin, melatonin, or both can reduce stent-related urinary symptoms and improve sleep after ureteroscopic stone treatment.
-
Urine, perineal, and stool microbiota in children and adolescents
We will test whether the bacteria in voided urine, around the genitals, and in stool differ between children with overactive bladder or daytime wetting and healthy children of the same age and gender.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.